Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.34 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.34 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.34 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.34 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.34 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.34 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17297259 | 0.86 | SMN1; SMN2 (0.49) | MAPTALDH1A1LMNAKDM4EHPGD | |
| SCHEMBL19490690 | 0.84 | SIRT2 (0.41) | MAPTALDH1A1LMNAKDM4EHPGD | |
| SCHEMBL19490943 | 0.78 | SIRT2 (0.46) | MAPTALDH1A1KDM4EHPGDCA1 | |
| SCHEMBL16620938 | 0.78 | ALDH1A1 (0.50) | MAPTALDH1A1LMNAKDM4EHPGD | |
| SCHEMBL802774 | 0.78 | ALDH1A1 (0.60) | MAPTALDH1A1LMNAKDM4EHPGD | |
| SCHEMBL16620935 | 0.78 | ALDH1A1 (0.50) | MAPTALDH1A1LMNAKDM4EHPGD | |
| SCHEMBL3365481 | 0.78 | ALDH1A1 (0.60) | MAPTALDH1A1LMNAKDM4EHPGD | |
| Lithium Ion SCHEMBL3399785 | 0.77 | ALDH1A1 (0.59) | MAPTALDH1A1LMNAKDM4EHPGD | |
| SCHEMBL19490692 | 0.75 | SMN1; SMN2 (0.63) | MAPTALDH1A1LMNAKDM4EHPGD | |
| SCHEMBL16621180 | 0.74 | ALDH1A1 (0.55) | MAPTALDH1A1LMNAKDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10364316-B2 | Conjugated polymer containing ethynyl crosslinking group, mixture, formulation, organic electronic device containing the same and application therof | GUANGZHOU CHINARAY OPTOELECTRONICS MATERIALS LTD. (CN) | 2019-07-30 | — | — | US | disclosed |
| US-20180022865-A1 | CONJUGATED POLYMER CONTAINING ETHYNYL CROSSLINKING GROUP, MIXTURE COMPOSITION, ORGANIC ELECTRONIC DEVICE CONTINAING THE SAME AND APPLICATION THEROF | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2018-01-25 | — | — | US | disclosed |
| US-20170365789-A1 | COMPOUND, MIXTURE COMPRISING THE SAME, COMPOSITION AND ORGANIC ELECTRONIC DEVICE | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2017-12-21 | — | — | US | disclosed |
| US-9796684-B2 | Materials for organic electroluminescence devices | MERCK PATENT GMBH (DE) | 2017-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170365789-A1 | COMPOUND, MIXTURE COMPRISING THE SAME, COMPOSITION AND ORGANIC ELECTRONIC DEVICE | DDT, DRD3, ICMT | MAPT 846/4885ALDH1A1 2400/4885LMNA 3321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.